Longboard Pharmaceuticals Inc (LBPH) Company Projected Revenue

Official company branding of longboardpharma.com (LBPH)

The development of drugs for rare brain pathologies is limited by strict FDA oversight and capital intensity, which has become the primary trigger for the market. GURU.Markets quotes form this chart, where the sales forecast for Longboard Pharmaceuticals (LBPH) demonstrates investor reaction, and the value of 0.00 captures this metric. The business foundation relies on CNS innovations and the delegation of trials to external CRO partners.

LBPH - longboardpharma.com Company Revenue Forecast over the range 07/04/2022 - 12/07/2024

Longboard Pharma - analytical breakdowns and key metrics (LBPH)

Fundamental valuation:longboardpharma.com
Signature product of Longboard Pharmaceuticals Inc

Analyzing future cash flows is critical for assessing an issuer's financial stability during screening. This metric recalculates expected revenue daily, transforming discrete reporting into a continuous indicator of market reliability. For Longboard Pharmaceuticals (LBPH), this calculation confirms the capitalization of bexicaserin patents and the success of clinical trials. By analyzing the company's future sales vector, an investor determines the business's ability to maintain asset value. A stable upward trend confirms the strengthening of its competitive advantage.

Analysis of competing companies

Company Future Sales Volume BIIB (Biogen)|NBIX (Neurocrine Biosciences, Inc.) - Company Future Revenue|Company Projected Revenue Regencell RGC|Company Projected Revenue Volume AXSM (Axsome Therapeutics Inc)|ACADIA Pharmaceuticals - Projected Sales Volume|XENE - Projected Sales Volume|VKTX: Projected Sales Volume|Company Expected Revenue SUPN (Supernus)|CPRX (Catalyst Pharmaceuticals Inc) - Projected Sales Volume|DNLI: Company Future Revenue|Company Projected Revenue harmonybiosciences.com (HRMY)|Biohaven - Company Revenue Forecast|Projected Sales Volume AMLX (amylyx.com)|Trevi Pharma (TRVI) - Company Expected Sales Volume|Praxis Corp - Projected Sales Volume|Anavex Corp (AVXL) - Company Future Sales Volume|CBLL: Projected Sales Volume|Prothena Biosciences - Company Future Revenue|ALEC (alector.com) - Projected Sales Volume|Company Revenue Forecast ANNX (Annexon Biosciences)|Company Projected Revenue Omeros Corporation (OMER)|Neurogene Corp - Company Revenue Forecast|Company Projected Revenue AC Immune S.A. ACIU|Company Future Sales Voyager Therapeutics (VYGR)|Neumora - Projected Sales Volume|Company Expected Revenue SCLX|Tevogen Bio Inc. (TVGN) - Company Projected Revenue|Company Revenue Forecast ACOG|CGTX (cogrx.com) - Projected Sales Volume|Company Future Sales Volume inhibikase.com (IKT)|Company Projected Revenue Cassava Sciences Inc (SAVA)|Company Future Sales Assertio|Projected Sales Volume COYA (Coya Therapeutics, Inc.)|Company Projected Revenue Volume VTGN (VistaGen Therapeutics Inc)|OVID: Company Future Sales Volume|ABOS: Company Projected Revenue|CervoMed (CRVO) - Company Projected Revenue|Company Expected Sales Volume Alterity Therapeutics Ltd (ATHE)|CLNN (Clene) - Projected Sales Volume|Company Revenue Forecast PEPG (PepGen)|Company Future Sales Volume JUNS (Jupiter Neurosciences, Inc.)|Projected Sales Volume relmada.com (RLMD)|Company Projected Revenue Annovis Bio Corp ANVS|GRCE: Company Revenue Forecast|AIFF - Company Projected Revenue|KLTO (anewmeds.com) - Company Revenue Forecast|NRSN (NeuroSense Therapeutics Ltd.) - Company Future Sales Volume|revivapharma.com - Company Future Revenue|MTVA (metaviatx.com) - Projected Sales Volume|NRXS: Company Future Revenue|Projected Sales Volume HSDT|PASG - Company Expected Sales Volume|Projected Sales Volume NEUP (Neuphoria Therapeutics)|NERV: Company Revenue Forecast|ATHA: Company Future Sales Volume|Addex Therapeutics Ltd - Company Projected Revenue Volume|Alzamend Neuro, Inc. (ALZN) - Company Projected Revenue|CYCN (Cyclerion Therapeutics Inc.) - Company Projected Revenue|Company Future Sales Volume PTIX|KTTA: Company Future Revenue|Company Future Sales Volume CRGT (Cortigent Medical)|ATXI (Avenue Therapeutics, Inc.) - Company Future Revenue|Company Projected Revenue Brainstorm Cell Therapeutics, Inc. BCLI|Company Future Revenue CARA|chromocell.com - Projected Sales Volume|Company Expected Revenue ELYM|ITCI: Projected Sales Volume|Marinus Pharmaceuticals Inc - Company Future Revenue|Company Future Sales Volume NKGN|NeuroBo - Company Expected Revenue|Company Projected Revenue Sage Therapeutics, Inc (SAGE)|Company Future Sales Volume Synaptogenix SNPX|Trevena, Inc. - Company Future Sales Volume|VIGL: Company Revenue Forecast|WENA: Company Future Sales Volume|Company Expected Sales Volume Cerevel Therapeutics